1. Home
  2. KZIA vs GP Comparison

KZIA vs GP Comparison

Compare KZIA & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • GP
  • Stock Information
  • Founded
  • KZIA 1994
  • GP 2010
  • Country
  • KZIA Australia
  • GP Canada
  • Employees
  • KZIA N/A
  • GP N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • KZIA Health Care
  • GP Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • GP Nasdaq
  • Market Cap
  • KZIA 9.0M
  • GP 10.5M
  • IPO Year
  • KZIA 1999
  • GP 2020
  • Fundamental
  • Price
  • KZIA $7.94
  • GP $3.96
  • Analyst Decision
  • KZIA Strong Buy
  • GP Strong Buy
  • Analyst Count
  • KZIA 2
  • GP 1
  • Target Price
  • KZIA $14.00
  • GP $30.00
  • AVG Volume (30 Days)
  • KZIA 137.3K
  • GP 261.5K
  • Earning Date
  • KZIA 11-14-2025
  • GP 11-13-2025
  • Dividend Yield
  • KZIA N/A
  • GP N/A
  • EPS Growth
  • KZIA N/A
  • GP N/A
  • EPS
  • KZIA N/A
  • GP N/A
  • Revenue
  • KZIA $1,549,158.00
  • GP $18,399,688.00
  • Revenue This Year
  • KZIA N/A
  • GP $81.12
  • Revenue Next Year
  • KZIA $49.25
  • GP $91.69
  • P/E Ratio
  • KZIA N/A
  • GP N/A
  • Revenue Growth
  • KZIA 248983.08
  • GP N/A
  • 52 Week Low
  • KZIA $2.86
  • GP $2.28
  • 52 Week High
  • KZIA $39.05
  • GP $18.50
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 48.43
  • GP 57.05
  • Support Level
  • KZIA $7.60
  • GP $3.09
  • Resistance Level
  • KZIA $8.28
  • GP $3.66
  • Average True Range (ATR)
  • KZIA 0.51
  • GP 0.45
  • MACD
  • KZIA 0.03
  • GP 0.09
  • Stochastic Oscillator
  • KZIA 30.88
  • GP 99.51

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: